Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$540.60
+0.5%
$535.82
$413.82
$616.00
$192.83B1.641.67 million shs1.49 million shs
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$155.59
-0.2%
$153.63
$140.68
$169.99
$375.15B0.418.05 million shs5.54 million shs
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
+0.49%+3.64%-2.29%+9.30%+23.20%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
-0.14%+2.14%+0.14%-2.69%+6.55%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
4.327 of 5 stars
2.43.00.04.03.02.51.9
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
4.8504 of 5 stars
2.35.04.23.93.11.71.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
2.70
Moderate Buy$588.958.94% Upside
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
2.55
Moderate Buy$170.889.83% Upside

Current Analyst Ratings Breakdown

Latest JNJ and ISRG Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/9/2025
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeHold ➝ Sell$515.00 ➝ $440.00
6/5/2025
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Erste Group Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy
6/5/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$181.00
5/22/2025
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$590.00 ➝ $650.00
5/13/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
5/13/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Leerink Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Market Perform$169.00 ➝ $153.00
4/24/2025
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$684.00 ➝ $635.00
4/24/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
4/23/2025
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$630.00 ➝ $605.00
4/23/2025
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$670.00 ➝ $575.00
4/23/2025
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$605.00 ➝ $590.00
(Data available from 7/3/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$8.35B23.20$8.03 per share67.35$46.41 per share11.65
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$88.82B4.21$13.10 per share11.88$29.69 per share5.24
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$2.32B$6.8279.2770.855.7128.41%14.43%12.81%7/17/2025 (Estimated)
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$14.07B$8.9917.3114.062.3624.42%33.46%13.30%7/16/2025 (Estimated)

Latest JNJ and ISRG Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/17/2025Q2 2025
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$1.92N/AN/AN/A$2.35 billionN/A
7/16/2025Q2 2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$2.65N/AN/AN/A$22.85 billionN/A
4/22/2025Q1 2025
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$1.71$1.81+$0.10$1.92$2.19 billion$2.25 billion
4/15/2025Q1 2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$2.59$2.77+$0.18$4.54$21.65 billion$21.89 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
N/AN/AN/AN/AN/A
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$5.203.34%N/A57.84%64 Years

Latest JNJ and ISRG Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/15/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
quarterly$1.303.37%5/27/20255/27/20256/10/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
N/A
4.98
3.97
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.49
1.26
1.03

Institutional Ownership

CompanyInstitutional Ownership
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
83.64%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
69.55%

Insider Ownership

CompanyInsider Ownership
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
0.70%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.16%
CompanyEmployeesShares OutstandingFree FloatOptionable
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
15,638358.42 million355.91 millionOptionable
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
138,1002.41 billion2.40 billionOptionable

Recent News About These Companies

Nurix subleases former Johnson & Johnson offices south of SF
AI builds ideal dividend stock portfolio for H2 2025

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Intuitive Surgical stock logo

Intuitive Surgical NASDAQ:ISRG

$540.60 +2.61 (+0.49%)
Closing price 07/2/2025 04:00 PM Eastern
Extended Trading
$539.34 -1.26 (-0.23%)
As of 07/2/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

Johnson & Johnson stock logo

Johnson & Johnson NYSE:JNJ

$155.59 -0.33 (-0.21%)
Closing price 07/2/2025 03:59 PM Eastern
Extended Trading
$155.34 -0.25 (-0.16%)
As of 07/2/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.